Medical Mission to Church Planting
This session will enable participants to understand the necessity for demonstration and...
Medical Mission to Church Planting
This session will enable participants to understand the necessity for demonstration and...
Dr. Hannah Valentine is a cardiologist whose research has focused on improving the management of...
51:10
Dr. Hannah Valentine is a cardiologist whose research has focused on improving the management of...
51:10
Bypass Surgery Without Wound Complications: Myth or Reality? - UCSF Vascular Symposium 2016
Warren Gasper, MD, Division of Vascular and Endovascular Surgery, UCSF. Series: "UCSF Vascular...
08:04
Heart Healthy Eating - Research on Aging
Learn the latest practical dietary suggestions to reduce risk and progression of heart disease,...
01:22:14
Can Robot-Assisted Surgery Carve a Niche in Ophthalmology?
Last month, a surgeon performed ophthalmology’s first robot-assisted surgery – a membrane peel....
30:29
BrainScope Scores FDA approval for Concussion Dx Device, Moves into Commercialization
Backed by nearly $30 million from the Department of Defense, BrainScope created a device to make...
26:46
Medtech M&A: McEvoy on Where Will AMO Fit into J&J & What the Deal Means for Eye Care
Ashley McEvoy, Company Group Chairman, Johnson & Johnson Vision Care and Johnson & Johnson...
11:18
From the Fundraising Front: How Rox Medical Made the Move to Hypertension and Raised $40m
Rox Medical CEO Rodney Brenneman says he’s never had a tougher time raising capital. But the deed...
35:44
Everything Medtech Companies Need to Know About Making Friends (& Closing Deals) in China
Chen Yu, MD, managing director of Vivo Capital, has built a career finding the right deals at the...
30:56
Where Are Series A Dollars Coming From? What Areas Are Ripe for M&A? You May Be Surprised
Data guru Jon Norris, managing director at Silicon Valley Bank, reviews his first-half numbers...
17:48
ReVision CEO John Kilcoyne Says the Company is Ready to Build a New Medtech Market in Ophthalmology
ReVision Optics built it – a corneal inlay capable of correcting presbyopia. The FDA approved it...
27:34
What Will Carl Zeiss Meditec’s New Ophthalmology Unit Look Like? We Ask Jim Mazzo.
Meet the newest Master of the Industry. Jim Mazzo, who has led divisions, spin-outs, and...
25:25
From an "Ah, Ha!" Moment to Restoring Sight – Innovator Mark Humayun, MD, on What Drives Innovation
Over two decades ago, Mark Humayun – who will co-chair our upcoming OIS@ASRS meeting in San...
24:24
Cartiva’s FDA Win for Approval of First Synthetic Cartilage Signals Change for Orthopedics
Cartiva secured an historic win when the FDA approved its synthetic cartilage. CEO Tim Patrick...
33:48
Perfecting the Fast-Follower Strategy – How Blue Belt Built and Sold a Successful Robotics Business
Eric Timko, the former CEO of Blue Belt, shares how the company used MAKO’s wake to build a...
29:14
How Do You Build a Start-Up into a $600 Million Exit? We Ask Matt Likens, Former CEO of Ulthera
The board at Ulthera, an aesthetics device company, faced an attractive dilemma. Take the company...
40:05
Gilde Healthcare’s Geoff Pardo on Why European LPs & VCs See Opportunity in the US Medtech Market
Gilde Healthcare Partner Geoff Pardo shares how the firm will invest its new $250 million in...
35:43
Allen Partners’ Julie Allen on How New Leaders Can Find Success in Today’s Evolving Medtech Sector
Julie Allen, principal of Allen Partners, shares insights on how Medtech executives must work to...
40:35
Sounds from the Stage: Hear "What it Takes to Win in Medtech" from Four Successful CEOs
The experienced CEOs on this panel have authored some of the greatest stories in Medtech. In this...
36:29